mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.7 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.7 |
mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.7 |
mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
-0.023 |
0.7 |
mRNA |
Roscovitine |
FIMM |
pan-cancer |
AAC |
0.069 |
0.7 |